Trial Profile
A Phase II Prospective, Randomised, Double-Blind, Placebo-Controlled Study to Assess the Efficacy of the Influenza Vaccine GHB11L1 Administered Intranasally Against a Controlled Influenza Virus Challenge in Healthy Adults.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 26 Sep 2013
Price :
$35
*
At a glance
- Drugs Influenza virus delta-NS1 vaccine (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Therapeutic Use
- 17 Nov 2011 New trial record